Simponi
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
Name | Simponi |
---|---|
Active Substance | golimumab |
Prescription | na recept |
Type of prescription | ograničeni recept (otopina za injekciju u napunjenoj brizgalici, otopina za injekciju u napunjenoj štrcaljki) |
Distribution | u ljekarni |
ATC Code | L04AB06 |
Medicinal product marketed in the Croatia | Nestašica |
Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
Link to the European Medicines Agency's (EMA) product information | download |
Link to the European Commission's (EC) decisions | download |
Educational materials for patients / caregivers |
Kartica s podsjetnikom za bolesnika |
Direct Healthcare Professional Communication
Name | Date | Download |
---|---|---|
Pismo zdravstvenim radnicima o važnim izmjenama uputa za ubrizgavanje brizgalicom SmartJect napunjenom lijekom Simponi (golimumab) | 09.08.2023 | Janssen Biologics B.V. |